Earnings · China A-shares

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class A (688796) earnings

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class A published its Q3 report on 2026-10-29: net profit +173.77% year on year, +307.62% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -13.65% in the 3 trading days after the report.

Report
Q3 report
Published
2026-10-29
Period end
2026-09-30
Net profit YoY
+173.77%
Excl. one-offs YoY
+307.62%
Net profit QoQ
-47.94%
Result
Great
Quality score
100
Quality
Sound
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day-6.32%—
3 days-13.65%—
7 days-4.57%—
14 days-21.78%—

Report history

Over the last 8 reports, net profit grew year on year in 6 of them. The stock rose in the 3 trading days after 1 of 4 reports (average -0.88%).

ReportPublishedNet profitProfit YoYExcl. one-offs YoYRevenue YoYEPSROE3 days after30 days after30d vs index
2026 Q3 report2026-10-30¥312.45M+173.77%+307.62%+49.09%0.7013.38%-13.65%——
2026 interim report2026-08-28¥241.09M+402.29%+591.53%+51.60%0.5410.49%-0.31%-29.34%-19.65%
2026 Q1 report2026-04-28¥104.03M+885.41%+789.46%+73.68%0.234.67%-2.39%-11.44%-10.82%
2025 Q1 report2026-04-28-¥13.25M———-0.03-1.59%-2.39%-11.44%-10.82%
2025 annual report2026-03-27¥173.20M+416.37%+405.39%+40.63%0.4316.85%+12.85%+18.31%+6.46%
2025 Q3 report2025-11-20¥114.13M+211.59%+159.48%+59.50%0.2912.61%———
2025 interim report2025-09-17¥48.00M+194.72%+151.54%+51.27%0.125.56%———
2024 Q3 report2025-09-17-¥102.27M———-0.26-13.67%———

The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.

Stock valuations: 688796

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.